Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_assertion type Assertion NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_head.
- NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_assertion description "[Based on the estimation from the hierarchical modeling, subjects who carried OGG1 326C/326C homozygotes, MGMT 143V or 178R, and CHEK2 157I had an odds ratio of lung cancer equal to 1.45 95% confidence interval (95% CI), 1.05-2.00, 1.18 (95% CI, 1.01-1.40), and 1.58 (95% CI, 1.14-2.17).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_provenance.
- NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_assertion evidence source_evidence_literature NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_provenance.
- NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_assertion SIO_000772 18086781 NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_provenance.
- NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_assertion wasDerivedFrom gad-20150221 NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_provenance.
- NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_assertion wasGeneratedBy ECO_0000203 NP68757.RAVxIN-oxeQh2quYTLZ2FwrpXxvoAokPK1M8f7pURWAf0130_provenance.